Boldenone Undecylenate 300
Chemical Name: 1,4-androstadiene-3-one, 17 beta-ol, 1-dehydrotestosterone
Molecular Weight: 286.409 g/mol
Original Manufacturer: Ciba
Half Life: 14 days
Detection Time: 4 – 5 months
Anabolic Rating: 100
Androgenic Rating: 50
Boldenone undecylenate is a derivative of testosterone with similar androgenic activity and higher mytrophic activity. Boldenone undecylenate does not convert into estrogens and does not have estrogen-related side effects. Instead, boldenone undecylenate is converted by -5alpha-reductase into dihydroboldenone and some of it’s androgenic effect mediated by dihydroboldenone.
Boldenone undecylenate increases overall body metabolism rate and increases appetite. Increase in lean body mass and low side effects make this anabolic/androgenic steroid (AAS) a good therapeutic choice for age-related non-genomic muscle degenerative diseases like sarcopenia. The undecylenate ester extends half-life of boldenone in circulation, which, depending on dose, is approximately seven days.
Dosage and administration
Male : 300-900 mg per week by intramuscular injection .
Female : 150- 450 mg per week by intramuscular injection.
Geriatric patients treated with androgens may be at an increased risk for the development of prostatic hypertrophy and prostatic carcinoma. The same precautions have to be taken as with other AAS convertible into DHT.
Store between 5C – 25C in adray space,protected from light
10 ml vial with aleaﬂet.